Metformine sandoz 850 mg filmomhulde tabletten (DrugBank: Metformine)
21 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
2 | Amyotrophic lateral sclerosis | 0 |
6 | Parkinson disease | 0 |
13 | Multiple sclerosis/Neuromyelitis optica | 0 |
46 | Malignant rheumatoid arthritis | 0 |
49 | Systemic lupus erythematosus | 0 |
60 | Aplastic anemia | 0 |
67 | Polycystic kidney disease | 0 |
75 | Cushing disease | 0 |
77 | Growth hormone secreting pituitary adenoma | 0 |
81 | Congenital adrenal hyperplasia | 1 |
86 | Pulmonary arterial hypertension | 0 |
113 | Muscular dystrophy | 0 |
127 | Frontotemporal lobar degeneration | 0 |
158 | Tuberous sclerosis | 0 |
206 | Fragile X syndrome | 0 |
225 | Congenital nephrogenic diabetes insipidus | 0 |
233 | Wolfram syndrome | 0 |
265 | Lipodystrophy | 0 |
285 | Fanconi anemia | 0 |
299 | Cystic fibrosis | 0 |
301 | Macular dystrophy | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | EUCTR2013-002395-40-BE (EUCTR) | 24/03/2014 | 19/11/2013 | Prospective intervention trial with adjuvant metformin in girls and boys with classic congenital adrenal hyperplasia. | Prospective intervention trial with adjuvant metformin in girls and boys with classic CAH (METFOR CAH). - METFOR CAH | congenital adrenal hyperplasia (CAH) MedDRA version: 16.1;Level: LLT;Classification code 10010323;Term: Congenital adrenal hyperplasia;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | Trade Name: Metformine Sandoz 850 mg filmomhulde tabletten Product Name: Metformine INN or Proposed INN: METFORMIN HYDROCHLORIDE Other descriptive name: METFORMIN HYDROCHLORIDE | Ghent University Hospital | NULL | Not Recruiting | Female: yes Male: yes | 90 | Phase 3 | Belgium |